Calistoga Pharmaceuticals' Series B Round

Calistoga Pharmaceuticals raised a round of funding on May 06, 2009.

Calistoga Pharmaceuticals is a biopharmaceutical company developing multiple compounds selectively targeting the PI3K pathway, a pathway known to be involved in certain cancers and inflammatory diseas…

Articles about Calistoga Pharmaceuticals' Series B Round: